Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Caliber Is Launched As Vaccine Company
by Ann M. Thayer
May 2, 2011
| A version of this story appeared in
Volume 89, Issue 18
A new company, Caliber Biotherapeutics, has opened a facility in Bryan-College Station, Texas, that makes pharmaceuticals grown in plants. According to the company, the facility can produce 10 million to 100 million vaccine doses per month and hundreds of thousands of doses of protein therapeutics. Caliber is commercializing the results of an alliance between Texas A&M University and facility developer G-Con that was backed by a $40 million Department of Defense grant to support vaccine production in tobacco. Caliber also intends to develop drugs to treat cancer and infectious diseases.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter